| Announce Date | 12/10/2025 |
| EPS Normalized Actual | $5.5 (Beat by $0.1) |
| EPS GAAP Actual | $5.5 (Beat by $0.1) |
| Revenue Actual | $6.194B |
| Revenue Surprise | Beat by $6194M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Nov 2030 | 33.01 | 8.09 | 31.94688 | 33.95233 | 2 |
| Nov 2030 | 33.01 | 8.09 | 31.94307 | 33.69352 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 4.45 | 4.45 | 6.194B | 9.49% | 6194M |
| FQ3 2025 (Aug 2025) | 4.18 | 4.18 | 5.988B | 9.69% | 5988M |
| FQ2 2025 (May 2025) | 3.95 | 3.95 | 5.873B | 9.6% | 5873M |
| FQ1 2025 (Feb 2025) | 4.15 | 4.15 | 5.714B | 9.31% | 5714M |
| FQ4 2024 (Nov 2024) | 3.82 | 3.82 | 5.606B | 9.95% | 5606M |
| FQ3 2024 (Aug 2024) | 3.78 | 3.78 | 5.408B | 9.58% | 5408M |
| FQ2 2024 (May 2024) | 3.5 | 3.5 | 5.309B | 9.29% | 5309M |
| FQ1 2024 (Mar 2024) | 1.37 | 1.37 | 5.182B | 10.17% | 5182M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Aug 2028) | 7.3965 | -- | 7.31111 | 7.48628 | 15 |
| FQ2 2028 (May 2028) | 7.19356 | -- | 7.11051 | 7.28088 | 8 |
| FQ1 2028 (Feb 2028) | 7.3218 | -- | 7.23727 | 7.41067 | 10 |
| FQ4 2027 (Nov 2027) | 6.69002 | -- | 6.64679 | 6.82202 | 14 |
| FQ3 2027 (Aug 2027) | 6.47546 | -- | 6.43531 | 6.60495 | 14 |
| FQ2 2027 (May 2027) | 6.23366 | -- | 6.19501 | 6.35832 | 14 |
| FQ1 2027 (Feb 2027) | 6.23893 | -- | 6.21035 | 6.29386 | 13 |
| FQ4 2026 (Nov 2026) | 5.98212 | 25.61 | 5.94346 | 6.10015 | 27 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ3 2028 (Aug 2028) | 7.78B | -- | 7.71B | 7.85B | 11 |
| FQ2 2028 (May 2028) | 7.65B | -- | 7.58B | 7.72B | 7 |
| FQ1 2028 (Feb 2028) | 7.48B | -- | 7.41B | 7.55B | 7 |
| FQ4 2027 (Nov 2027) | 7.28B | -- | 7.24B | 7.39B | 20 |
| FQ3 2027 (Aug 2027) | 7.06B | -- | 7.02B | 7.17B | 13 |
| FQ2 2027 (May 2027) | 6.95B | -- | 6.92B | 7.06B | 13 |
| FQ1 2027 (Feb 2027) | 6.81B | -- | 6.78B | 6.85B | 8 |
| FQ4 2026 (Nov 2026) | 6.69B | 7.43 | 6.66B | 6.79B | 13 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | 4.45 | 4.45 | 100% | |
| FQ3 2025 (Aug 2025) | 4.18 | 4.18 | 100% | |
| FQ2 2025 (May 2025) | 3.95 | 3.95 | 100% | |
| FQ1 2025 (Feb 2025) | 4.15 | 4.15 | 100% | |
| FQ4 2024 (Nov 2024) | 3.82 | 3.82 | 100% | |
| FQ3 2024 (Aug 2024) | 3.78 | 3.78 | 100% | |
| FQ2 2024 (May 2024) | 3.5 | 3.5 | 100% | |
| FQ1 2024 (Mar 2024) | 1.37 | 1.37 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Nov 2025) | $0B | $6.19B | $6194M | 100% |
| FQ3 2025 (Aug 2025) | $0B | $5.99B | $5988M | 100% |
| FQ2 2025 (May 2025) | $0B | $5.87B | $5873M | 100% |
| FQ1 2025 (Feb 2025) | $0B | $5.71B | $5714M | 100% |
| FQ4 2024 (Nov 2024) | $0B | $5.61B | $5606M | 100% |
| FQ3 2024 (Aug 2024) | $0B | $5.41B | $5408M | 100% |
| FQ2 2024 (May 2024) | $0B | $5.31B | $5309M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $5.18B | $5182M | 100% |